Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Pharmacology

• Publication date

  2012-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2012.07.041PMID 22959357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function.

  2011cited by this paper
• Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome.

  2011cited by this paper
• Phospholipid scramblase: An update

  2010cited by this paper
• Calcium-dependent phospholipid scrambling by TMEM16F

  2010cited by this paper
• Clinical and basal aspects of anemia during antiviral therapy for hepatitis C.

  2009cited by this paper
• Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.

  2009cited by this paper
• P4 ATPases - lipid flippases and their role in disease.

  2009cited by this paper
• Morphological transformation and phosphatidylserine exposure in erythrocytes treated with ribavirin.

  2009cited by this paper
• Development of novel treatments for hepatitis C.

  2009cited by this paper
• Viral hepatitis: New data on hepatitis C infection

  2008cited by this paper
• Erythrocyte programmed cell death

  2008cited by this paper
• Regulation of phospholipid asymmetry in the erythrocyte membrane

  2008cited by this paper
• Epidemiology of hepatitis C virus infection.

  2007cited by this paper
• Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy.

  2006cited by this paper
• Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.

  2006cited by this paper
• Surface exposure of phosphatidylserine in pathological cells

  2005cited by this paper
• Mechanisms of Suicidal Erythrocyte Death

  2005cited by this paper
• Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.

  2004cited by this paper
• Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids.

  2004cited by this paper
• ATP and GSH dependence of MRP1-mediated outward translocation of phospholipid analogs in the human erythrocyte membrane

  2003cited by this paper
• Cation channels trigger apoptotic death of erythrocytes

  2003cited by this paper
• Binding of annexin V to membrane products of lipid peroxidation.

  2001cited by this paper
• A receptor for phosphatidylserine-specific clearance of apoptotic cells

  2000cited by this paper
• Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage

  2000cited by this paper
• Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes

  2000cited by this paper
• Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis

  2000cited by this paper
• Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes.

  2000cited by this paper
• The clinical pharmacology of ribavirin.

  1999cited by this paper
• Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine‐sensitive (es)‐nucleoside transporters

  1998cited by this paper
• Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes.

  1997cited by this paper
• The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling.

  1995cited by this paper
• Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement.

  1993cited by this paper
• Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process.

  1992cited by this paper
• The metabolism of ribavirin in erythrocytes and nucleated cells.

  1990cited by this paper
• Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages.

  1986cited by this paper
• In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes.

  1985cited by this paper
• Glycophorin facilitates the transbilayer movement of phosphatidylcholine in vesicles.

  1978cited by this paper
• Glycophorin facilitates the transbilayer movement of phosphatidylcholine in vesicles.

  1978cited by this paper
• Inside-outside transitions of phospholipids in vesicle membranes.

  1971cited by this paper

• Calcium oxalate alters lipid profiles and annexin A2 enrichment in membrane fractions of murine inner medullary collecting duct cells.

  2025cites this paper
• Red Blood Cell Extracellular Vesicle-Based Drug Delivery: Challenges and Opportunities

  2021cites this paper
• Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes

  2020cites this paper
• DHEA prevents ribavirin‐induced anemia via inhibition of glucose‐6‐phosphate dehydrogenase

  2017cites this paper
• Autophagy suppression sensitizes glioma cells to IMP dehydrogenase inhibition‐induced apoptotic death

  2017cites this paper
• Coagulation testing in atherosclerosis and liver disease

  2016cites this paper
• Damage repair mechanisms in sensory hair cells

  2015influential citation
• Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach

  2015cites this paper